Jie-Er Ying Selected Research

Jie-Er Ying Research Topics

6	Neoplasms (Cancer) 12/2023 - 05/2021
6	Stomach Neoplasms (Stomach Cancer) 12/2023 - 11/2008
2	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
1	Microsatellite Instability 12/2023
1	Cholangiocarcinoma 09/2023
1	Nausea 10/2022
1	Vomiting 10/2022
1	Malnutrition (Nutritional Deficiencies) 10/2022
1	Adenocarcinoma 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2012
1	Disease Progression 11/2008

2	Gemcitabine FDA Link 09/2023 - 02/2012
2	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2014
1	human ERBB2 proteinIBA 12/2023
1	exatecan (DX 8951f)IBA 09/2023
1	monomethyl auristatin EIBA 09/2023
1	AntibodiesIBA 09/2023
1	AntigensIBA 09/2023
1	Immunoconjugates (Immunoconjugate)IBA 09/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2023
1	ElectrolytesIBA 10/2022
1	AntiemeticsIBA 10/2022
1	Olanzapine (Zyprexa)FDA Link 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	XELOXIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	PlatinumIBA 11/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2008
1	Docetaxel (Taxotere)FDA Link 11/2008

3	Neoadjuvant Therapy 12/2023 - 01/2021
3	Immunotherapy 12/2023 - 01/2021
3	Therapeutics 12/2023 - 11/2008
3	Drug Therapy (Chemotherapy) 10/2022 - 11/2008
1	Precision Medicine 12/2023
1	Radiotherapy 10/2022
1	Combination Drug Therapy (Combination Chemotherapy) 11/2008